← Leaderboards
Jae H Kang
Brigham And Women'S Hospital
$5,060,591
Attributed
$6,884,332
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,884,332 · 5
By mechanism
R01$6,243,075 · 3
R21$485,557 · 1
R03$155,700 · 1
Top collaborators
- Janey L Wiggs4 shared
- Louis Robert Pasquale2 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Charles A Czeisler$60,536,935
- Elizabeth B Klerman$20,560,158
- Jeanne F Duffy$12,938,067
- Eva S Schernhammer$12,735,461
- Frank A Scheer$22,110,197
Others in their field
Top investigators on “Participant”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$407,724,307
- Lawrence Corey · Fred Hutchinson Cancer Center$333,313,234
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Albert Lazzarini · California Institute Of Technology$300,431,866
Research focus
ParticipantPlasmaIntakeDiagnosisFundingHealth StudyPrimary PreventionNurses&AposSamplingFollow-UpProspectiveCostQuestionnairesGeneral PopulationAgedGeneticFollow-Up StudiesCase ControlGenomicsBiologicalBiobankDiagnosticDesignDisorder Prevention
Grant awards (15)
Multiomic Framework for Glaucoma$780,260
R01 · FY2025 · EY
Genetic and Environmental Risk Factors for Exfoliation Syndrome and Glaucoma$426,396
R01 · FY2025 · EY
Multiomic Framework for Glaucoma$813,213
R01 · FY2024 · EY
Genetic and Environmental Risk Factors for Exfoliation Syndrome and Glaucoma$496,614
R01 · FY2024 · EY
Genetic and Environmental Risk Factors for Exfoliation Syndrome and Glaucoma$564,365
R01 · FY2023 · EY
Genetic and Environmental Risk Factors for Exfoliation Syndrome and Glaucoma$566,634
R01 · FY2022 · EY
Advance Care Planning and Health Care Utilization in Aging Women$255,179
R21 · FY2017 · AG · contact PI
Advance Care Planning and Health Care Utilization in Aging Women$230,378
R21 · FY2016 · AG · contact PI
A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive Decline$494,257
R01 · FY2015 · AG · contact PI
A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive Decline$494,393
R01 · FY2013 · AG · contact PI
A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive Decline$538,404
R01 · FY2012 · AG · contact PI
A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive Decline$533,331
R01 · FY2011 · AG · contact PI
A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive Decline$535,208
R01 · FY2010 · AG · contact PI
Plasma Markers of Dietry Intervention to Delay Cognitiv*$77,850
R03 · FY2005 · AG
Plasma Markers of Dietary Intervention to Delay Cogniti$77,850
R03 · FY2004 · AG